Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: Teicoplanin versus vancomycin in a retrospective study

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 6-7, 2008, Pages 462-467

  Huang, Jih Hsin ^a   Hsu, Ron Bin ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFMETAZOLE; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; FLUCONAZOLE; GANCICLOVIR; GENTAMICIN; IMIPENEM; METRONIDAZOLE; OXACILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG FEVER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; LEUKOPENIA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MORTALITY; NONHUMAN; PROSTHESIS INFECTION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; ENDOCARDITIS; FEMALE; HOSPITALS; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN; TEICOPLANIN; TREATMENT OUTCOME; VANCOMYCIN;

EID: 47349124282     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701837126     Document Type: Article

References (25)

1. Roder, BL, Wandall, DA, Frimodt-Moller, N., Espersen, F., Skinhoj, P. and Rosdahl, VT. (1999) Clinical features of Staphylococcus aureus endocarditis: A 10-y experience in Denmark. Arch Intern Med, 159, pp. 462-469.
2. Fowler Jr, VG, Sanders, LL, Kong, LK, McClelland, RS, Gottlieb, GS Li, J. et al. (1999) Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis, 28, pp. 106-114.
3. Hsu, RB and Chu, SH. (2004) Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus. Am J Med Sci, 328, pp. 150-155.
4. Gentry, CA, Rodvold, KA, Novak, RM, Hershow, RC and Naderer, OJ. (1997) Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy, 17, pp. 990-997.
5. Levine, DP, Fromm, BS and Reddy, BR. (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med, 115, pp. 674-680.
6. Sherwood, M., Smith, D., Crisel, R., Veledar, E. and Lerakis, S. (2006) Staphylococcus aureus endocarditis: The Grady Memorial Hospital Experience. Am J Med Sci, 331, pp. 84-87.
7. Chang, FY, MacDonald, BB, Peacock Jr, JE, Musher, DM, Triplett, P. Mylotte, JM et al. (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine, 82, pp. 322-332.
8. Li, JS, Sexton, DJ, Mick, N., Nettles, R., Fowler Jr, VG Ryan, T. et al. (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis, 30, pp. 633-638.
9. Wang, JT, Chang, SC, Ko, WJ, Chang, YY, Chen, ML Pan, HJ et al. (2001) A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect, 47, pp. 104-109.
10. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC and Hughes, JM. (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control, 16, pp. 128-140.
11. Stein, DS and Nelson, KE. (1987) Endocarditis due to nutritionally deficient streptococci: Therapeutic dilemma. Rev Infect Dis, 9, pp. 908-916.
12. Klevens, RM, Edwards, JR, Tenover, FC, McDonald, LC, Horan, T., Gaynes, R. and National Nosocomial Infections Surveillance System (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis, 42, pp. 389-391.
13. Hsueh, PR, Chen, ML, Sun, CC, Chen, WH, Pan, HJ Yang, LS et al. (2002) Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis, 8, pp. 63-68.
14. Wang, JT, Chen, YC, Yang, TL and Chang, SC. (2002) Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis, 42, pp. 199-203.
15. Harbarth, S., Rutschmann, O., Sudre, P. and Pittet, D. (1998) Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med, 158, pp. 182-189.
16. Chesi, G., Colli, A., Mestres, CA, Gambarati, G., Boni, F. and Gherli, T. (2006) Multiresistant-MRSA tricuspid valve infective endocarditis with ancient osteomyelitis locus. BMC Infect Dis, 6, p. 124.
17. Ozkurt, Z., Erkut, B., Kadanali, A., Ates, A. and Yekeler, I. (2005) Nosocomial methicillin-resistant Staphylococcus aureus endocarditis with splenic abscess in a pregnant woman. Jpn J Infect Dis, 58, pp. 323-325.
18. Demey, HE, Eycken, M., Vandermast, M. and Bossaert, LL. (1991) Purulent pericarditis due to methicillin-resistant Staphylococcus aureus. A case report. Acta Cardiol, 46, pp. 485-491.
19. Wood, MJ. (1996) The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother, 37, pp. 209-222.
20. Sipahi, OR, Arda, B., Yurtseven, T., Sipahi, H., Ozgiray, E., Suntur, BM and Ulusoy, S. (2005) Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Int J Antimicrob Agents, 26, pp. 412-415.
21. Arda, B., Yamazhan, T., Sipahi, OR, Islekel, S., Buke, C. and Ulusoy, S. (2005) Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): Review of 10 cases. Int J Antimicrob Agents, 25, pp. 414-418.
22. May, J., Shannon, K., King, A. and French, G. (1998) Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother, 42, pp. 189-197.
23. Segreti, JA, Crank, CW and Finney, MS. (2006) Daptomycin for the treatment of Gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients. Pharmacotherapy, 26, pp. 347-352.
24. Nathani, N., Iles, P. and Elliott, TS. (2005) Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: A case report. J Infect, 51, pp. 213-215.
25. Bassetti, M., Di Biagio, A, Del Bono, V, Cenderello, G. and Bassetti, D. (2004) Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid. Int J Antimicrob Agents, 24, pp. 83-84.